Hemab’s $135 Million Series B Financing Round

Mazanti-Andersen advised Hemab on the deal.The Denmark and US-based biotech company Hemab raised USD 135 million in oversubscribed series B financing. Access Biotechnology led the round with…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now